Figure 1 Overall worldwide prevalence ranges for SLE

Slides:

Advertisements

Similar presentations

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

Advertisements

DOMESTIC ENVIRONMENT AND SOCIO-ECONOMIC FACTORS OF TUBERCULOSIS IN BANDUNG AND WEST TIMOR TITIK RESPATI GILARSI.

Economics 172 Issues in African Economic Development Lecture 9 February 13, 2006.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Figure 3 The induction of anti-DNA antibodies by bacterial DNA

Figure 3 Life expectancy at birth in all countries included

Figure 1 Male infertility and assisted reproduction globally

Figure 3 Connexins in cartilage

Figure 5 Involvement of B cells in SLE

Figure 1 Historical evolution of the clinical classification and

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Grip strength across the lifecourse

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 4 Ex vivo synovial tissue culture viability

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Global epidemiology of common Clostridium difficile ribotypes

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Targeted versus untargeted metabolomics approaches

Figure 3 Simplified EULAR and GRAPPA

Figure 2 Simplified EULAR and GRAPPA

Figure 4 Antinuclear antibodies and disease activity in SLE

Figure 2 The network of chronic diseases and their mutual influences

Figure 2 Shared genetic loci in systemic autoimmune diseases

Figure 1 The burden of chronic kidney disease (CKD)

Figure 3 Nucleic acid sensors in SLE

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Overlap of associated loci among five rheumatic diseases

Global burden of hypertension in the adult population

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Statistical approaches for the analysis of metabolomic data

Figure 1 Cardiovascular risk and disease across the life-course

Figure 3 Cell-surface markers for NP cell differentiation

Figure 6 Lack of IRF5 causes a reduction in neutrophil influx

Figure 3 Multi-hit model for autoimmune diseases

Figure 2 Global cost of HF per capita in 2012

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 2 Age-specific prevalence of common comorbidities

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Ischaemic stroke prevalence and mortality

Figure 1 Treat to target, remission and low disease activity in SLE

Figure 1 Biospecimen handling pipeline

Figure 1 The current model of the pathogenesis of SLE

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Impact of New Hepatitis C Treatments in Different Regions of the World

Figure 1 Principles for the diagnosis and management of osteoarthritis

Figure 1 Patient, facility, health-care system and industry factors

Figure 2 Embryonic origins of tissue-resident macrophages

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Chronic inflammation and DNA damage in people with SLE

Figure 1 Worldwide distribution of disease burden attributable to environmental risks in 2012 Figure 1 | Worldwide distribution of disease burden attributable.

Maps showing the age-adjusted prevalence of T2D as proportion of the total population aged 20–79 years in 2015, worldwide (A); urban proportion, as proportion.

Foot maps showing the patterns of average tissue stress, peak tissue stress, urate deposition in gout and bone erosion in gout. Foot maps showing the patterns.

Figure 3 Global iodine status and mandatory salt iodization

Figure 2 The main effects of adipokines on bone remodelling in osteoarthritis Figure 2 | The main effects of adipokines on bone remodelling in osteoarthritis.

Positivity rates and concordance of multiplex PCR and blood culture (BC) results from 27 published studies. Positivity rates and concordance of multiplex.

Presentation transcript:

Figure 1 Overall worldwide prevalence ranges for SLE Figure 1 | Overall worldwide prevalence ranges for SLE. Reported SLE prevalence ranges per country (per 100,000 of the population) are shown, as denoted by the key. The number of studies (n =) indicate those from which each prevalence range was determined. Note the dual shading of Spain, indicating that the prevalence values span two neighbouring ranges. Precise overall prevalence ranges per country are outlined in Table 1, in which data for Mainland China and Taiwan are listed independently. Nature Reviews Rheumatology remains neutral with regard to jurisdictional claims in published maps. Carter, E. E. et al. (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2016.137